Cellular receptors for plasminogen activators recent advances. (Q47772665)

5 February 2018

title

Cellular receptors for plasminogen activators recent advances. (English)

1 reference

5 February 2018

1 reference

V Ellis

1

1 reference

5 February 2018

publication date

1 October 1997

1 reference

5 February 2018

Trends in Cardiovascular Medicine

published in

1 reference

5 February 2018

volume

7

1 reference

5 February 2018

issue

7

1 reference

5 February 2018

page(s)

227-234

1 reference

5 February 2018

A novel, specific pro-urokinase complex on monocyte-like cells, detected by transglutaminase-catalyzed cross-linking

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Physiological consequences of loss of plasminogen activator gene function in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Impaired arterial neointima formation in mice with disruption of the plasminogen gene

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Prevention of metastasis by inhibition of the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Structure of a soluble, glycosylated form of the human complement regulatory protein CD59

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

High-affinity urokinase receptor antagonists identified with bacteriophage peptide display

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

The urokinase receptor is required for human monocyte chemotaxis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Binding of tissue plasminogen activator to cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

The urokinase receptor is a major vitronectin-binding protein on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Upregulation of urokinase receptor expression on migrating endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Chemical modification of the urokinase-type plasminogen activator and its receptor using tetranitromethane. Evidence for the involvement of specific tyrosine residues in both molecules during receptor-ligand interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Impaired wound healing in mice with a disrupted plasminogen gene

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Characterization of 125I-tissue plasminogen activator binding to cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Regulation of integrin function by the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2897%2900084-4

7 January 2021

10.1016/S1050-1738(97)00084-4

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

21235889

1 reference

5 February 2018